Aspartic protease inhibitor 7 Antibody

What is Aspartic protease inhibitor 7 and what organisms express it?

Aspartic protease inhibitor 7 (API7) is a protein found primarily in Solanum tuberosum (potato) that functions to regulate aspartic protease activity. This protein plays a crucial role in plant defense mechanisms against pathogens and stress conditions by inhibiting enzymatic activity of endogenous and exogenous aspartic proteases. Unlike many protease inhibitors that target serine or cysteine proteases, API7 specifically targets aspartic proteases, which are characterized by catalytic aspartate residues in their active sites . The protein has been documented in the UniProt database with the accession number Q41448 .

What are the basic applications of Aspartic protease inhibitor 7 Antibody in research?

The Aspartic protease inhibitor 7 Antibody is primarily used in plant biochemistry and molecular biology research for:

• Western Blot (WB) analysis - For detection and quantification of API7 protein expression in plant tissues and extracts

• Enzyme-Linked Immunosorbent Assay (ELISA) - For quantitative measurement of API7 in complex samples

• Immunohistochemistry - Though not explicitly mentioned in product specifications, polyclonal antibodies against plant proteins can often be optimized for tissue localization studies

The antibody enables researchers to study expression patterns, regulation mechanisms, and functional aspects of API7 in plant biology, particularly in stress response and pathogen defense pathways.

How should Aspartic protease inhibitor 7 Antibody be stored and handled for optimal results?

For optimal stability and activity, Aspartic protease inhibitor 7 Antibody should be stored according to these guidelines:

Proper storage conditions are critical to maintain antibody specificity and sensitivity. The preservative Proclin 300 helps prevent microbial contamination during handling .

How can Aspartic protease inhibitor 7 Antibody be used to investigate plant stress responses?

The Aspartic protease inhibitor 7 Antibody can be employed in advanced plant stress research through several methodological approaches:

• Temporal expression profiling: Using Western blot analysis with the antibody to track API7 expression before, during, and after exposure to various stressors (pathogens, temperature extremes, drought conditions)

• Subcellular localization studies: Combining the antibody with subcellular fractionation techniques to determine the compartmentalization of API7 under stress conditions

• Protease-inhibitor interaction assays: Using the antibody in co-immunoprecipitation experiments to pull down API7 along with interacting aspartic proteases in plant tissues

• Quantitative changes in different plant tissues: ELISA-based quantification of API7 in different tissues to map systemic response patterns

A comprehensive experimental design should include appropriate controls and consider potential cross-reactivity with other aspartic protease inhibitors in the same family (API1-11) that are structurally similar .

How does the interaction between Aspartic protease inhibitor 7 and its target proteases compare with other protease-inhibitor systems?

The interaction between API7 and aspartic proteases represents a specialized inhibitory mechanism that differs from other protease-inhibitor systems in several important aspects:

• Binding mechanism: Unlike serine protease inhibitors that often use a "canonical" binding loop, aspartic protease inhibitors typically interact with the catalytic aspartate residues through a more complex mechanism involving hydrogen bonding networks and hydrophobic interactions

• Specificity profile: API7 likely demonstrates higher specificity toward plant aspartic proteases compared to broad-spectrum inhibitors like Pepstatin A, which inhibits most aspartic proteases regardless of source

• pH dependency: The interaction between API7 and its target proteases is likely optimal at acidic pH (typically 3.5-5.5), similar to other aspartic protease systems where activity and inhibition are pH-dependent

• Structural considerations: While many protease inhibitors work through competitive inhibition by mimicking substrates, aspartic protease inhibitors often contain specific structural elements that allow them to form stable complexes with the catalytic site

This comparison highlights the need for specific detection tools like the API7 antibody when studying this particular inhibitor-protease system rather than using general aspartic protease detection methods.

What is the optimal protocol for using Aspartic protease inhibitor 7 Antibody in Western blot analysis?

The following protocol optimizes detection of Aspartic protease inhibitor 7 in plant samples by Western blot:

Sample Preparation:

• Extract total protein from plant tissue using a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, and protease inhibitor cocktail (without aspartic protease inhibitors if studying natural inhibition)

• Quantify protein concentration using Bradford or BCA assay

• Prepare samples with reducing buffer and heat at 95°C for 5 minutes

SDS-PAGE and Transfer:

• Load 20-50 μg protein per lane on 12-15% polyacrylamide gel

• Run gel at 100V until dye front reaches bottom

• Transfer to PVDF membrane at 100V for 1 hour or 30V overnight at 4°C

Immunoblotting:

• Block membrane with 5% non-fat milk in TBST for 1 hour at room temperature

• Incubate with Aspartic protease inhibitor 7 Antibody at 1:500-1:2000 dilution in blocking buffer overnight at 4°C

• Wash 3× with TBST, 10 minutes each

• Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour at room temperature

• Wash 3× with TBST, 10 minutes each

• Develop using ECL substrate and image

Critical Controls:

• Positive control: Recombinant Aspartic protease inhibitor 7 protein

• Negative control: Plant extract from species not expressing API7

• Pre-immune serum control: To assess background staining

How can researchers design experiments to study the functional interaction between API7 and aspartic proteases?

To effectively study the functional interaction between API7 and target aspartic proteases, researchers should consider these methodological approaches:

1. In vitro inhibition assays:

• Purify recombinant API7 using the antibody for immunoaffinity purification

• Set up enzymatic assays using known aspartic proteases (e.g., potato aspartic proteases) with fluorogenic substrates

• Measure inhibition constants (Ki) across different pH values (3.0-6.0) and temperatures

• Compare with standard inhibitors like Pepstatin A as reference

2. Structural analysis:

• Use purified API7-protease complexes for crystallization trials

• Perform site-directed mutagenesis of key residues identified by structural studies

• Validate structure-function relationships using the antibody to confirm expression and folding of mutants

3. Cellular localization studies:

• Use cell fractionation followed by immunoblotting with the API7 antibody

• Perform immunohistochemistry on plant tissue sections to determine spatial distribution

• Correlate API7 localization with known aspartic protease distribution

4. Physiological function analysis:

• Design gene silencing/knockout studies targeting API7

• Use the antibody to confirm protein reduction/absence

• Assess phenotypic changes and aspartic protease activity alterations

• Complement with exogenous API7 to confirm specific effects

These approaches should be combined for comprehensive understanding of API7 function in plant systems.

How do I troubleshoot non-specific binding when using Aspartic protease inhibitor 7 Antibody?

When encountering non-specific binding with Aspartic protease inhibitor 7 Antibody, implement this systematic troubleshooting approach:

Common causes and solutions:

Advanced troubleshooting:

• Use pre-immune serum as negative control to identify background

• Perform peptide competition assay using the immunogen peptide to confirm specificity

• Consider tissue-specific extraction protocols to improve protein isolation

• For plant tissues with high phenolic content, include PVPP in extraction buffer to reduce interference

How should results from Aspartic protease inhibitor 7 Antibody experiments be interpreted in the context of protease inhibition mechanisms?

Interpreting results from experiments using the Aspartic protease inhibitor 7 Antibody requires careful consideration of underlying protease inhibition mechanisms:

1. Expression vs. Activity Correlation:

• Detection of API7 using the antibody indicates presence but not necessarily activity

• Correlate antibody-based detection with functional inhibition assays

• Consider that post-translational modifications may affect inhibitory function without altering antibody detection

2. Mechanistic Interpretation:

• Unlike small molecule inhibitors (e.g., Pepstatin A) that directly block active sites, protein inhibitors like API7 may have complex binding mechanisms

• Changes in API7 levels detected by the antibody should be interpreted in the context of known aspartic protease inhibition mechanisms

• Remember that most aspartic proteases function optimally at acidic pH (3.5-5.5), and inhibition studies should consider this pH range

3. Comparative Analysis Framework:

• Compare results with other aspartic protease inhibitors (API1-6, API8-11) to identify specific vs. general inhibition patterns

• Use the Morrison equation for tight-binding inhibitor analysis when quantifying inhibition constants

• Consider that even complete inhibition of one aspartic protease may not eliminate all protease activity due to functional redundancy

4. Biological Context:

• Elevated API7 expression may indicate stress response rather than constitutive inhibition

• Temporal changes in expression should be considered when interpreting developmental or stress response data

• Different plant tissues may show varying baseline expression levels that influence interpretation of relative changes

How do detection methods for Aspartic protease inhibitor 7 compare with approaches for other protease inhibitor classes?

Detection methods for Aspartic protease inhibitor 7 have distinct characteristics compared to approaches for other protease inhibitor classes:

For aspartic protease inhibitors like API7, the antibody-based detection provides excellent specificity but requires complementary enzymatic inhibition assays (typically at acidic pH) to confirm functional activity. Unlike activity-based probes used for some protease classes, the antibody approach does not directly distinguish between active and inactive inhibitor forms .

What are the current limitations in understanding the structural basis of API7 inhibition, and how might they be addressed?

Current limitations in understanding the structural basis of API7 inhibition and potential research approaches to address them:

Current Limitations:

• Limited structural data: Unlike HIV protease inhibitors or other well-characterized aspartic protease systems, the three-dimensional structure of API7 and its complexes with target proteases remains poorly characterized

• Unknown binding kinetics: The association and dissociation rates of API7 with its target proteases, which determine inhibition effectiveness under physiological conditions, are not well established

• Incomplete target profile: The full spectrum of aspartic proteases inhibited by API7 and the relative inhibition strengths have not been comprehensively mapped

• Undefined specificity determinants: The structural features that confer specificity for particular aspartic proteases remain unclear

Advanced Research Approaches:

• Structural biology approaches:

  • X-ray crystallography of API7 alone and in complex with target proteases

  • NMR studies to map interaction interfaces

  • Cryo-EM analysis of larger complexes

• Computational modeling:

  • Molecular dynamics simulations to predict binding modes

  • Virtual screening to identify small molecules that mimic API7 binding

• Protein engineering:

  • Site-directed mutagenesis of API7 guided by computational predictions

  • Domain swapping between different API family members to identify specificity regions

  • Creation of chimeric inhibitors to test binding hypotheses

• Advanced spectroscopic techniques:

  • Hydrogen-deuterium exchange mass spectrometry to map binding interfaces

  • Single-molecule FRET to measure binding dynamics

  • Surface plasmon resonance to determine binding kinetics

These approaches would significantly advance our understanding of the structural basis of API7 inhibition and potentially lead to novel applications in biotechnology and agriculture.

How might Aspartic protease inhibitor 7 Antibody be used in developmental studies of plant defense mechanisms?

The Aspartic protease inhibitor 7 Antibody offers promising applications in studying developmental aspects of plant defense mechanisms through several methodological approaches:

• Temporal expression mapping:

  • Sample plant tissues at different developmental stages

  • Use the antibody in Western blot and immunohistochemistry to create a spatiotemporal map of API7 expression

  • Correlate expression patterns with developmental transitions and susceptibility to pathogens

• Stress-induced developmental reprogramming:

  • Apply biotic/abiotic stressors at different developmental stages

  • Monitor API7 expression changes using the antibody

  • Determine if API7 induction follows different patterns depending on developmental context

• Transgenerational studies:

  • Expose parent plants to stressors that induce API7 expression

  • Use the antibody to assess API7 baseline expression in offspring

  • Investigate potential epigenetic mechanisms if transgenerational effects are observed

• Methodological innovations:

  • Combine the antibody with laser capture microdissection to analyze API7 expression in specific cell types

  • Develop API7-reporter fusions and validate with the antibody

  • Create in situ hybridization protocols to correlate mRNA and protein levels using the antibody as validation

This research would significantly advance our understanding of how protease inhibitor-based defense mechanisms are integrated into plant developmental programs.

What are the potential applications of comparative studies between different aspartic protease inhibitors using antibody-based detection?

Comparative studies of different aspartic protease inhibitors using antibody-based detection offer several promising research directions:

• Evolutionary analysis of inhibitor specialization:

  • Use antibodies against different API family members (API1-11) to map expression patterns across plant species

  • Correlate inhibitor profiles with ecological niches and pathogen exposure

  • Reconstruct the evolutionary history of aspartic protease inhibitor diversification

• Cross-reactivity profiling for functional groups:

  • Test antibody cross-reactivity between API family members

  • Identify conserved epitopes that might indicate functional domains

  • Use this information to develop pan-API antibodies for broader detection

• Inhibitor cocktail optimization:

  • Determine which combinations of aspartic protease inhibitors are naturally expressed during different stress conditions

  • Use antibody-based quantification to establish natural inhibitor ratios

  • Apply this knowledge to engineer optimized protease inhibitor mixtures for crop protection

• Structure-function relationship mapping:

  • Compare inhibitory activities of different API family members detected with specific antibodies

  • Correlate structural differences with inhibitory potency and specificity

  • Develop predictive models for rational design of novel inhibitors

• Methodological considerations:

  • Develop multiplexed detection systems using differentially labeled antibodies

  • Create standard curves for each inhibitor to enable accurate quantification

  • Establish tissue-specific extraction protocols that preserve all API family members equally